These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37794898)

  • 21. Dyslipidemia in relation to body mass index and insulin resistance in Chinese women with polycystic ovary syndrome.
    Hong Y; Yang D; Liu W; Zhao X; Chen X; Li L
    J Biol Regul Homeost Agents; 2011; 25(3):365-74. PubMed ID: 22023761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women.
    Kheirollahi A; Teimouri M; Karimi M; Vatannejad A; Moradi N; Borumandnia N; Sadeghi A
    Lipids Health Dis; 2020 Nov; 19(1):235. PubMed ID: 33161896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma visfatin and apelin levels in adolescents with polycystic ovary syndrome.
    Ruan X; Li M; Min M; Ju R; Wang H; Xu Z; Luo S; Mueck AO
    Gynecol Endocrinol; 2023 May; 39(1):2216807. PubMed ID: 37248950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of insulin resistance with lipid profile, metabolic syndrome, and hormonal aberrations in overweight or obese women with polycystic ovary syndrome.
    Ebrahimi-Mamaghani M; Saghafi-Asl M; Pirouzpanah S; Aliasgharzadeh A; Aliashrafi S; Rezayi N; Mehrzad-Sadaghiani M
    J Health Popul Nutr; 2015 Mar; 33(1):157-67. PubMed ID: 25995732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical study on treating insulin resistance and promoting ovulation in polycystic ovary syndrome].
    Liu ZA; Xue YM; Chen LX; Cai Q; Chen H; Zhang J; Cui QH; Ge J; Yuan T
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):586-90. PubMed ID: 15498183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S; Akhtar N; Ahmad J
    Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome.
    Butler AE; Moin ASM; Reiner Ž; Sathyapalan T; Jamialahmadi T; Sahebkar A; Atkin SL
    Front Endocrinol (Lausanne); 2023; 14():1117761. PubMed ID: 37181037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of serum β-trophin and endostatin in patients with polycystic ovary syndrome: Are they correlated?
    Gong W; Bilixzi A; Wang X; Lu Y; Wan L; Han L
    BMC Womens Health; 2021 Mar; 21(1):104. PubMed ID: 33706732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L:A ratio, Insulin resistance and metabolic risk in women with polycystic ovarian syndrome.
    Gupta V; Mishra S; Mishra S; Gupta V
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S697-S701. PubMed ID: 28529126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of C1q/TNF-related protein-3 (CTRP3) in serum of patients with gestational diabetes mellitus and its relationship with insulin resistance.
    Li JY; Wu GM; Hou Z; Cao YM
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5702-5710. PubMed ID: 29272006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum fibrinogen-like protein 1 as a novel biomarker in polycystic ovary syndrome: a case-control study.
    Zhang Y; Dilimulati D; Chen D; Cai M; You H; Sun H; Gao X; Shao X; Zhang M; Qu S
    J Endocrinol Invest; 2022 Nov; 45(11):2123-2130. PubMed ID: 35790683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of the triglyceride-glucose index and non-traditional blood lipid parameters in predicting metabolic syndrome in women with polycystic ovary syndrome.
    Zhang L; Wang H; Ma Q; Liu Y; Chen A; Lu J; Ren L
    Hormones (Athens); 2023 Jun; 22(2):263-271. PubMed ID: 36790635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between kisspeptin and biochemical markers in obese and non-obese women with polycystic ovary syndrome.
    Gao M; Tao X; Zhang Q; He W; Zhao T; Yuan T
    Gynecol Endocrinol; 2023 Dec; 39(1):2215869. PubMed ID: 37236245
    [No Abstract]   [Full Text] [Related]  

  • 34. Is Xanthine oxidase activity in polycystic ovary syndrome associated with inflammatory and cardiovascular risk factors?
    Isık H; Aynıoglu O; Tımur H; Sahbaz A; Harma M; Can M; Guven B; Alptekin H; Kokturk F
    J Reprod Immunol; 2016 Aug; 116():98-103. PubMed ID: 27295433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of PON1 activity and circulating TF levels in relation to BMI, testosterone, HOMA-IR, HDL-C, LDL-C, CHO, SOD activity and TAC in women with PCOS: An observational study.
    Jeelani H; Ganie MA; Masood A; Amin S; Kawa IA; Fatima Q; Manzoor S; Parvez T; Naikoo NA; Rashid F
    Diabetes Metab Syndr; 2019; 13(5):2907-2915. PubMed ID: 31425955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
    Li Y; Wei LN; Xiong YL; Liang XY
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):567-70. PubMed ID: 21029609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of Homeostatic Model Assessment-Insulin Resistance, Anti-Mullerian Hormone, and BMI in the Characterization of Polycystic Ovary Syndrome.
    Bahadur A; Verma N; Mundhra R; Chawla L; Ajmani M; Sri MS; Arora S
    Cureus; 2021 Jun; 13(6):e16047. PubMed ID: 34336524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between glomerular filtration rate, and metabolic and inflammatory parameters in obese and non-obese patients with polycystic ovary syndrome.
    Can M; Duran C; Guney I; Elmas H; Ayhan M; Erdem SS
    Clin Investig Arterioscler; 2020; 32(6):256-262. PubMed ID: 32773256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
    Durmus U; Duran C; Ecirli S
    J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.